Correlation of three-dimensional tumor volumetry with cervical cancer prognostic parameters

Objective: Estimation of tumor size by a single diameter is used in the current Federal International Gynecology Oncology (FIGO) cervical cancer staging system. However, the role of three-dimensional volumetry is rarely mentioned. In this study, three kinds of tumor volume estimations were performed and the relationship of these volume estimations among associated cervical cancer prognostic parameters were evaluated.

Methods: Thirty patients with newly diagnosed cervical cancer at Taipei Veterans General Hospital were enrolled in the study. Final pathology and associated parametric information was obtained by chart review. The original magnetic resonance (MR) image was reappraised by an experienced radiologist and the tumor volume was estimated using either three axial measurements or the longest axial measurement. The corresponding three-dimensional (3-D) volume was calculated by the integration of lesion areas in different images using volumetric software developed by engineers at National Central University, Taiwan. All data were analyzed separately for correlation with clinical staging, histological differentiation, pelvic lymph node metastasis and survival status.

Results: A statistically significant difference in tumor volume estimates was found between 3-D-integration and one-dimensional estimates among tumors with lymph nodes metastasis, cell differentiation and parametrial involvement.

Conclusion: This study found that the parameters of lymph node metastasis, parametrial involvement and tumor differentiation are volume-dependent. 3D-tumor volumetry showed superior discrimination of these parameters compared to current single diameter evaluation suggesting its potential as a rapid method for initial prediction of prognostic factors in cervical cancer.

Tumor volumetry; 3-Dimensional volumetry; Stereologic volumetry; Cervical squamous cell carcinoma; Prognostic. factors

[1] "Leading Causes of Death from Cancer, for Females, Taiwan Area, 1991-1997". http://www.doh.gov. tw/englishlstatistics/c5.xls.

[2] "Leading Causes of Death from Cancer,f or Females.Taiwan Area, 1998". http://www.doh.gov.twlenglislvstatistics/c6.xls.

[3] Chen C. J., You S. L.: "Epidemiology of cervical cancer in Taiwan". Gynecol. Oneal., 1997, 67, 115.

[4] Shepherd J. H.: "Revised FIGO staging for gynaecological cancer". Br. J. Ohstet. Gynaecol., 1989, 96, 889.

[5] Grant J. M.: "Revised FIGO staging for early invasive carcmoma of the vulva and cervix". Br. J. Obstet. Gynaecol., 1996, 103, 21.

[6] Creasman W. T.: "New gynecologic cancer staging". Obstet. Gynecol.,1990, 75, 287.

[7] Hawnaur J. M., Johnson R. J.,H unter R. D., Jenkins J. P., Isherwood I.: "The value of magnetic resonance imaging in assessment of carcinoma of the cervix and its response to radiotherapy". Clin. Oneal. (R. Coll. Radiol.), 1992, 4, 11.

[8] Arimoto T.: "Significance of computed tomography-measured volume in the prognosis of cervical carcinoma". Cancer, 1993, 72, 2383.

[9] Sasaoka M., Nomoto Y., Shoji K., Kobayashi S., Toyota S., Nakagawa T.: "Radiation therapy for uterine cervix cancer: importance of evaluation of pre-treatment tumor size with MR imaging". Nippon lgaku Hoshasen Gakkai Zasshi,1997, 57, 505.

[10] Mamfredi R., Maresca G., Smaniotto D., Greggi S., Andrulli D., Rabitti C. et al.: "Cervical cancer response to neoadjuvant therapy: MR imaging assessment". Radiology, 1998, 209, 819.

[11] Burghardt E.,B altzer J.,T ulusan AH.,H aas J.: "Results of Surgical Treatment of 1028 Cervical Cancers Studied with Volumetry". Cancer, 1992, 70, 648.

[12] Yuan C. C., Wang P.H., Lai C. R., Yen M. S., Chen C. Y., Juang C. M.: "Prognosis predicting system based on factors related to survival of cervical carcinoma". Int. J. Gynecol. Obstet., 1998, 63, 163.

[13] Yuan C. C., Wang P.H., Lai C. R., Tsue E. J., Yen M. S., Ng H T.: "Recurrence and survival analysis of 1115 cervical cancer patients treated with radical hysterectomy". Gynecol. Obstet. Invest.,1999, 47, 127.

[14] Juang C. M., Wang P.H., Yen M. S., Lai C. R., Ng H. T., Yuan C C.: "Application of tumor markers CEA. TPA, and SCC-Ag in patients with low-risk FIGO stage IB and IIA squamous cell carcinoma of the uterine cervix". Gynecol. Oncol., 2000, 76, 103.

[15] Hayashi T., Kato T.: "Usefulness of tumor size on MR assessrng the prognosis of uterine cervical cancer treated with radiation". Nippon lgaku Hoshasen Gakkai Zasshi, 1999, 59, 250.

[16] Schaffer U.,H awighorst H.,P ilch H., Weikel W., Zuna I., Knapstein P. G.: "Value of clinically established MRI procedures concerning the pretherapeutic cervix cancer in relation to palpation finding and histopathologic whole mount specimens". Zentralbl Gynakol., 1999, 121, 131.

[17] Gong Q. Y., Tan L. T., Romaniuk C. S., Jones B., Brunt J. N., Roberts N.: "Determination of tumour regression rates during radiotherapy for cervical carcinoma by serial MRI: comparison of two measurement techniques and examination of intraobserver and interobserver variab山ty". Br. J. Radiol., 1999, 72, 62.

[18] Chou C. Y., Hus K. F., Wang S. T.,H uang S. C., Tzeng C. C., Huang K. E.: "Accuracy of three-dimensional ultrasonography in volume estimation of cervical carcinoma". Gynecol. Oncol., 1997, 66, 89.

[19] Suzuki M.: "Role of X-ray CT and magnetic resonance Imagmg in the diagnosis of gynecological malignant tumor". Nippon Sanka Fujinka Gakkai Zasshi. 1989, 41, 942.

[20] Hricak H.: "Cancer of the uterus: the value of MRI pre- and postirradiation". Int. J. Radial. Oncol. Biol. Phys., 1991, 21, 1089.

[21] Varpula M., Kilholma P., Lemi P.: "CT and ultra low field (0.02T) MR imaging of uterine cervical carcinoma". Acta Radio!., 1994, 35, 361.

[22] Mezrich R.: "Radiology in invasive cervical cancer". Mag. Reson Imaging Clin. N. Am., 1994, 2, 211.

[23] Cline H. E., Lorensen W. E., Ludke S., Crawford C. R., Teeter B C.:'Two algorithms for the three-dimensional reconstruction of tomograms". Med. Phys., 1998, 15, 320.

[24] Fischetti S. G.,C oppolino F.,P riolo G. D., Chiarenza R., Garufi A., Privitera G. et al.: "Mag netic resonance in the evaluation ot parametrial involvement in carcinoma of the cervix uteri". Radiol. Med. (Torino), 1991, 82, 470.

[25] Arimoto T.. Mizoe J., Kamada T., Tsujii H., Shirato H., Matsuoka Y. et al.: "CT-aided volumetry and prognosis in cervical carcinoma". Radial. Med., 1984, 2, 197.

[26] Arimoto T.: "Significance of computed tomography-measured volume in the prognosis of cervical carcinoma". Cancer, 1993, 72, 2383.

[27] Mayr N. A., Magnotta V. A., Ehrhardt J. C., W heeler J. A., Sorosky J. I.,W en B. C. et al.: "Usefulness of tumor volumetry by magnetic resonance imaging in asses、ing response to radiation therapy in carcinoma of the uterine cervix". Int. J. Radial. Oncol Biol. Phys., 1996, 35, 1113.